Table 2.
Association between gankyrin expression and clinicopathological features.
| Clinicopathological features | No. of patients (n) | Relative gankyrin expression | T | P | |
|---|---|---|---|---|---|
| High | Low | ||||
| Age | 0.785 | 0.435 | |||
| <45 | 9 | 5 (55.6%) | 4 (44.4%) | ||
| ≥45 | 68 | 39 (57.4%) | 29 (42.6%) | ||
| Gender | 1.898 | 0.062 | |||
| Male | 52 | 34 (65.4%) | 18 (34.6%) | ||
| Female | 25 | 11 (44.0%) | 14 (56.0%) | ||
| Lymph node metastasis | 2.401 | 0.019 | |||
| No | 20 | 9 (45.0%) | 11 (55.0%) | ||
| Yes | 57 | 35 (61.4%) | 22 (38.6%) | ||
| Distant metastasis | 2.532 | 0.013 | |||
| No | 55 | 27 (49.1%) | 28 (50.9%) | ||
| Yes | 22 | 17 (77.3%) | 5 (22.7%) | ||
| Pathological grade | 2.557 | 0.084 | |||
| I–II | 9 | 7 (77.8%) | 2 (22.2%) | ||
| III | 62 | 34 (54.8%) | 28 (45.2%) | ||
| IV | 6 | 3 (50.0%) | 3 (50.0%) | ||
| Vascular invasion | 2.122 | 0.037 | |||
| No | 20 | 9 (45.0%) | 11 (55.0%) | ||
| Yes | 57 | 35 (61.4%) | 22 (38.6%) | ||
Patients were divided by high gankyrin staining (H-score ≥ 145) and low gankyrin staining (H-score < 145).